A Phase 1, Open-Label, Non-Randomized, Fixed-Sequence Composite Study to Evaluate the Effects of Probenecid, Rifampin, and Verapamil on the Pharmacokinetics and Pharmacodynamics of Bexagliflozin in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 10 Jan 2018
At a glance
- Drugs Bexagliflozin (Primary) ; Probenecid; Rifampicin; Verapamil
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Theracos
- 04 Jan 2018 Status changed from recruiting to completed.
- 26 Oct 2017 Status changed from not yet recruiting to recruiting.
- 05 Oct 2017 New trial record